Dendritic cell metabolism: immunity and tolerance
Dendritic cell metabolism: immunity and tolerance |
https://doi.org/10.18632/oncotarget.5865
An-Sofie Vanherwegen,
Conny Gysemans,
and Lut Overbergh
|
34039-34040 |
Naa10 in development and disease
Naa10 in development and disease |
https://doi.org/10.18632/oncotarget.5867
Line M. Myklebust,
Svein I. Støve,
and Thomas Arnesen
|
34041-34042 |
Vinculin-cell membrane interactions
Vinculin-cell membrane interactions |
https://doi.org/10.18632/oncotarget.5868
David T. Brown,
and Tina Izard
|
34043-34044 |
Reducing genomic instability in iPSCs
Reducing genomic instability in iPSCs |
https://doi.org/10.18632/oncotarget.6212
Sergio Ruiz,
and Oscar Fernandez-Capetillo
|
34045-34046 |
Targeting lymphatics in inflammatory bowel disease
Targeting lymphatics in inflammatory bowel disease |
https://doi.org/10.18632/oncotarget.6026
Silvia D’Alessio,
Carlotta Tacconi,
and Silvio Danese
|
34047-34048 |
DNA methylation and demethylation dynamics
DNA methylation and demethylation dynamics |
https://doi.org/10.18632/oncotarget.6039
Francesco Neri,
Danny Incarnato,
and Salvatore Oliviero
|
34049-34050 |
DCIR in the “osteo-immune” system
DCIR in the “osteo-immune” system |
https://doi.org/10.18632/oncotarget.6043
Takumi Maruhashi,
Tomonori Kaifu,
and Yoichiro Iwakura
|
34051-34052 |
CCN1 in hepatobiliary injury repair
CCN1 in hepatobiliary injury repair |
https://doi.org/10.18632/oncotarget.6079
Ki-Hyun Kim,
and Lester F. Lau
|
34053-34054 |
ASK “to be, or not to be?”
ASK “to be, or not to be?” |
https://doi.org/10.18632/oncotarget.6105
Tomohiko Okazaki
|
34055-34056 |
Targeting RIPK1,2,3 to combat inflammation
Targeting RIPK1,2,3 to combat inflammation |
https://doi.org/10.18632/oncotarget.6106
Alex N. Bullock,
and Alexei Degterev
|
34057-34058 |
microRNAs calibrate T cell responses by regulating mTOR
microRNAs calibrate T cell responses by regulating mTOR |
https://doi.org/10.18632/oncotarget.6107
Matthias Merkenschlager,
and Antoine Marcais
|
34059-34060 |
TRIB3-P62 interaction, diabetes and autophagy
TRIB3-P62 interaction, diabetes and autophagy |
https://doi.org/10.18632/oncotarget.6108
Fang Hua,
and Zhuo-Wei Hu
|
34061-34062 |
The quest for GAS vaccine
The quest for GAS vaccine |
https://doi.org/10.18632/oncotarget.6140
Manisha Pandey,
and Michael F. Good
|
34063-34064 |
CXCL14: the Swiss army knife chemokine
CXCL14: the Swiss army knife chemokine |
https://doi.org/10.18632/oncotarget.6040
Charaf Benarafa,
and Marlene Wolf
|
34065-34066 |
Autophagy, microbiota and intestinal oncogenesis
Autophagy, microbiota and intestinal oncogenesis |
https://doi.org/10.18632/oncotarget.5966
Jonathan Lévy,
and Béatrice Romagnolo
|
34067-34068 |
NTHL1 defines novel cancer syndrome
NTHL1 defines novel cancer syndrome |
https://doi.org/10.18632/oncotarget.5864
Roland P. Kuiper,
and Nicoline Hoogerbrugge
|
34069-34070 |
Effects of a novel Nodal-targeting monoclonal antibody in melanoma
Effects of a novel Nodal-targeting monoclonal antibody in melanoma |
https://doi.org/10.18632/oncotarget.6049
Luigi Strizzi,
Annamaria Sandomenico,
Naira V. Margaryan,
Annalia Focà,
Luca Sanguigno,
Thomas M. Bodenstine,
Grace S. Chandler,
David W. Reed,
Alina Gilgur,
Elisabeth A. Seftor,
Richard E.B. Seftor,
Zhila Khalkhali-Ellis,
Antonio Leonardi,
Menotti Ruvo,
and Mary J.C. Hendrix
|
34071-34086 |
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer |
https://doi.org/10.18632/oncotarget.6048
Nidhi Bansal,
Kevin Petrie,
Rossitza Christova,
Chi-Yeh Chung,
Boris A. Leibovitch,
Louise Howell,
Veronica Gil,
Yordan Sbirkov,
EunJee Lee,
Joanna Wexler,
Edgardo V. Ariztia,
Rajal Sharma,
Jun Zhu,
Emily Bernstein,
Ming-Ming Zhou,
Arthur Zelent,
Eduardo Farias,
and Samuel Waxman
|
34087-34105 |
Identification of ageing-associated naturally occurring peptides in human urine
Identification of ageing-associated naturally occurring peptides in human urine |
https://doi.org/10.18632/oncotarget.5896
Esther Nkuipou-Kenfack,
Akshay Bhat,
Julie Klein,
Vera Jankowski,
William Mullen,
Antonia Vlahou,
Mohammed Dakna,
Thomas Koeck,
Joost P. Schanstra,
Petra Zürbig,
Karl L. Rudolph,
Björn Schumacher,
Andreas Pich,
and Harald Mischak
|
34106-34117 |
Aging with ING: a comparative study of different forms of stress induced premature senescence
Aging with ING: a comparative study of different forms of stress induced premature senescence |
https://doi.org/10.18632/oncotarget.5947
Uma Karthika Rajarajacholan,
and Karl Riabowol
|
34118-34127 |
Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice
Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice |
https://doi.org/10.18632/oncotarget.6021
Beibei Wu,
Yan Wei,
Yujing Wang,
Tao Su,
Lei Zhou,
Ying Liu,
and Rongqiao He
|
34128-34142 |
Suppression of FoxO6 by lipopolysaccharide in aged rat liver
Suppression of FoxO6 by lipopolysaccharide in aged rat liver |
https://doi.org/10.18632/oncotarget.6219
Dae Hyun Kim,
Min Hi Park,
Ki Wung Chung,
Min Jo Kim,
Daeui Park,
Bonggi Lee,
Eun Kyeong Lee,
Yeon Ja Choi,
Nam Deuk Kim,
Byung Pal Yu,
and Hae Young Chung
|
34143-34157 |
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells |
https://doi.org/10.18632/oncotarget.5779
Damiano Cosimo Rigiracciolo,
Andrea Scarpelli,
Rosamaria Lappano,
Assunta Pisano,
Maria Francesca Santolla,
Paola De Marco,
Francesca Cirillo,
Anna Rita Cappello,
Vincenza Dolce,
Antonino Belfiore,
Marcello Maggiolini,
and Ernestina Marianna De Francesco
|
34158-34177 |
Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome
Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome |
https://doi.org/10.18632/oncotarget.6213
Ebba Sohlberg,
Aline Pfefferle,
Sandra Andersson,
Bettina C. Baumann,
Eva Hellström-Lindberg,
and Karl-Johan Malmberg
|
34178-34190 |
Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide
Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide |
https://doi.org/10.18632/oncotarget.5763
Jia Kang,
Stephen Jun Fei Chong,
Vignette Zi Qi Ooi,
Shireen Vali,
Ansu Kumar,
Shweta Kapoor,
Taher Abbasi,
Jayshree L. Hirpara,
Thomas Loh,
Boon Cher Goh,
and Shazib Pervaiz
|
34191-34205 |
The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells
The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells |
https://doi.org/10.18632/oncotarget.5275
Sahithi Pamarthy,
Mukesh K. Jaiswal,
Arpita Kulshreshta,
Gajendra K. Katara,
Alice Gilman-Sachs,
and Kenneth D. Beaman
|
34206-34220 |
Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice
Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice |
https://doi.org/10.18632/oncotarget.5950
Luís Felipe Campesato,
Romualdo Barroso-Sousa,
Leandro Jimenez,
Bruna R. Correa,
Jorge Sabbaga,
Paulo M. Hoff,
Luiz F. L. Reis,
Pedro Alexandre F. Galante,
and Anamaria A. Camargo
|
34221-34227 |
Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma
Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma |
https://doi.org/10.18632/oncotarget.5349
Chase Taylor,
Holli A. Loomans,
Gregoire F. Le Bras,
Rainelli B. Koumangoye,
Alejandra I. Romero-Morales,
Laura L. Quast,
Alexander I. Zaika,
Wael El-Rifai,
Thomas Andl,
and Claudia D. Andl
|
34228-34244 |
JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia
JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia |
https://doi.org/10.18632/oncotarget.5196
Alessio Montresor,
Lara Toffali,
Michela Mirenda,
Antonella Rigo,
Fabrizio Vinante,
and Carlo Laudanna
|
34245-34257 |
Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway
Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway |
https://doi.org/10.18632/oncotarget.5545
Li-Juan Deng,
Qun-Long Peng,
Long-Hai Wang,
Jun Xu,
Jun-Shan Liu,
Ying-Jie Li,
Zhen-Jian Zhuo,
Liang-Liang Bai,
Li-Ping Hu,
Wei-Min Chen,
Wen-Cai Ye,
and Dong-Mei Zhang
|
34258-34275 |
Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH
Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH |
https://doi.org/10.18632/oncotarget.5371
Meirong Zang,
Dehui Zou,
Zhen Yu,
Fei Li,
Shuhua Yi,
Xiaofei Ai,
Xiaoqi Qin,
Xiaoyan Feng,
Wen Zhou,
Yan Xu,
Zengjun Li,
Mu Hao,
Weiwei Sui,
Shuhui Deng,
Chirag Acharya,
Yaozhong Zhao,
Kun Ru,
Lugui Qiu,
and Gang An
|
34276-34287 |
Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer
Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer |
https://doi.org/10.18632/oncotarget.5924
Sandra Schmitz,
Gabriela Bindea,
Roxana Irina Albu,
Bernhard Mlecnik,
and Jean-Pascal Machiels
|
34288-34299 |
Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients
Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients |
https://doi.org/10.18632/oncotarget.5549
Rui Wang,
Yang Zhang,
Yunjian Pan,
Yuan Li,
Haichuan Hu,
Deng Cai,
Hang Li,
Ting Ye,
Xiaoyang Luo,
Yiliang Zhang,
Bin Li,
Lei Shen,
Yihua Sun,
and Haiquan Chen
|
34300-34308 |
TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells
TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells |
https://doi.org/10.18632/oncotarget.5295
Xing Liu,
Weijia Liao,
Qing Yuan,
Ying Ou,
and Jian Huang
|
34309-34320 |
Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma
Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma |
https://doi.org/10.18632/oncotarget.5761
Susanne Holck,
Hans Jørgen Nielsen,
Niels Pedersen,
and Lars-Inge Larsson
|
34321-34328 |
Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation
Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation |
https://doi.org/10.18632/oncotarget.6020
Zhiqiang Liu,
Jingda Xu,
Jin He,
Huan Liu,
Pei Lin,
Xinhai Wan,
Nora M. Navone,
Qiang Tong,
Larry W. Kwak,
Robert Z. Orlowski,
and Jing Yang
|
34329-34341 |
Structural basis for the indispensable role of a unique zinc finger motif in LNX2 ubiquitination
Structural basis for the indispensable role of a unique zinc finger motif in LNX2 ubiquitination |
https://doi.org/10.18632/oncotarget.5326
Digant Nayak,
and J. Sivaraman
|
34342-34357 |
The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer
The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer |
https://doi.org/10.18632/oncotarget.6024
Jennifer Munkley,
Sebastian Oltean,
Daniel Vodák,
Brian T. Wilson,
Karen E. Livermore,
Yan Zhou,
Eleanor Star,
Vasileios I. Floros,
Bjarne Johannessen,
Bridget Knight,
Paul McCullagh,
John McGrath,
Malcolm Crundwell,
Rolf I. Skotheim,
Craig N. Robson,
Hing Y. Leung,
Lorna W. Harries,
Prabhakar Rajan,
Ian G. Mills,
and David J. Elliott
|
34358-34374 |
Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium
Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium |
https://doi.org/10.18632/oncotarget.6045
Subrahmanya D. Vallabhapurapu,
Víctor M. Blanco,
Mahaboob K. Sulaiman,
Swarajya Lakshmi Vallabhapurapu,
Zhengtao Chu,
Robert S. Franco,
and Xiaoyang Qi
|
34375-34388 |
Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis
Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis |
https://doi.org/10.18632/oncotarget.5360
Beny Shapiro,
Piera Tocci,
Gal Haase,
Nancy Gavert,
and Avri Ben-Ze’ev
|
34389-34401 |
The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway
The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway |
https://doi.org/10.18632/oncotarget.5353
Cong Guo,
Jia Su,
Zhijun Li,
Rui Xiao,
Jianxun Wen,
Yanyan Li,
Meng Zhang,
Xueting Zhang,
Donna Yu,
Wendong Huang,
Wei-Dong Chen,
and Yan-Dong Wang
|
34402-34413 |
The radiosensitivity index predicts for overall survival in glioblastoma
The radiosensitivity index predicts for overall survival in glioblastoma |
https://doi.org/10.18632/oncotarget.5437
Kamran A. Ahmed,
Prakash Chinnaiyan,
William J. Fulp,
Steven Eschrich,
Javier F. Torres-Roca,
and Jimmy J. Caudell
|
34414-34422 |
Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer
Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer |
https://doi.org/10.18632/oncotarget.5406
Yue Yu,
Ying Zhao,
Xiao-Hu Sun,
Jie Ge,
Bin Zhang,
Xin Wang,
and Xu-Chen Cao
|
34423-34436 |
TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes
TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes |
https://doi.org/10.18632/oncotarget.5255
Kathy L. McGraw,
Thomas Cluzeau,
David A. Sallman,
Ashley A. Basiorka,
Brittany A. Irvine,
Ling Zhang,
P.K. Epling-Burnette,
Dana E. Rollison,
Mar Mallo,
Lubomir Sokol,
Francesc Solé,
Jaroslaw Maciejewski,
and Alan F. List
|
34437-34445 |
MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence
MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence |
https://doi.org/10.18632/oncotarget.5920
Malathi Ramalinga,
Arpita Roy,
Anvesha Srivastava,
Asmita Bhattarai,
Varsha Harish,
Simeng Suy,
Sean Collins,
and Deepak Kumar
|
34446-34457 |
Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells
Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells |
https://doi.org/10.18632/oncotarget.5277
Mu Yao,
Chanlu Xie,
Mei-Yee Kiang,
Ying Teng,
David Harman,
Jessamy Tiffen,
Qian Wang,
Paul Sved,
Shisan Bao,
Paul Witting,
Jeff Holst,
and Qihan Dong
|
34458-34474 |
Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells
Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells |
https://doi.org/10.18632/oncotarget.5922
Andreas Ritter,
Alexandra Friemel,
Friderike Fornoff,
Mouhib Adjan,
Christine Solbach,
Juping Yuan,
and Frank Louwen
|
34475-34493 |
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.5417
Ina Kurth,
Linda Hein,
Katrin Mäbert,
Claudia Peitzsch,
Lydia Koi,
Monica Cojoc,
Leoni Kunz-Schughart,
Michael Baumann,
and Anna Dubrovska
|
34494-34509 |
RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma
RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.5923
Lan Zhang,
Jian-Hua Wang,
Rong-Xin Liang,
Shu-Ting Huang,
Jing Xu,
Lin-Jing Yuan,
Long Huang,
Yun Zhou,
Xing-Juan Yu,
Shao-Yun Wu,
Rong-Zhen Luo,
Jing-Ping Yun,
Wei-Hua Jia,
and Min Zheng
|
34510-34524 |
Characterisation of inflammatory processes in Helicobacter pylori-induced gastric lymphomagenesis in a mouse model
Characterisation of inflammatory processes in Helicobacter pylori-induced gastric lymphomagenesis in a mouse model |
https://doi.org/10.18632/oncotarget.5948
Pauline Floch,
Amandine Marine Laur,
Victoria Korolik,
Delphine Chrisment,
David Cappellen,
Yamina Idrissi,
Pierre Dubus,
Francis Mégraud,
and Philippe Lehours
|
34525-34536 |
Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit
Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit |
https://doi.org/10.18632/oncotarget.5307
Wuguang Lu,
Lingchong Qiu,
Zhanpeng Yan,
Zhibing Lin,
Meng Cao,
Chunping Hu,
Zhigang Wang,
Jin Wang,
Ye Yu,
Xiaoyang Cheng,
Peng Cao,
and Rongxiu Li
|
34537-34548 |
LGR5 is associated with tumor aggressiveness in papillary thyroid cancer
LGR5 is associated with tumor aggressiveness in papillary thyroid cancer |
https://doi.org/10.18632/oncotarget.5330
Gregory Michelotti,
Xiaoyin Jiang,
Julie Ann Sosa,
Anna Mae Diehl,
and Brittany Bohinc Henderson
|
34549-34560 |
Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts
Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts |
https://doi.org/10.18632/oncotarget.5949
Christopher H. Lieu,
Peter J. Klauck,
Patrick K. Henthorn,
John J. Tentler,
Aik-Choon Tan,
Anna Spreafico,
Heather M. Selby,
Blair C. Britt,
Stacey M. Bagby,
John J. Arcaroli,
Wells A. Messersmith,
Todd M. Pitts,
and S. Gail Eckhardt
|
34561-34572 |
Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death
Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death |
https://doi.org/10.18632/oncotarget.5312
Melissa Rosso,
Alla Polotskaia,
and Jill Bargonetti
|
34573-34591 |
ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation
ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation |
https://doi.org/10.18632/oncotarget.5423
Christina Hausmann,
Achim Temme,
Nils Cordes,
and Iris Eke
|
34592-34605 |
FXR induces SOCS3 and suppresses hepatocellular carcinoma
FXR induces SOCS3 and suppresses hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.5314
Fei Guo,
Zhizhen Xu,
Yan Zhang,
Peng Jiang,
Gang Huang,
Shan Chen,
Xilin Lyu,
Ping Zheng,
Xin Zhao,
Yijun Zeng,
Shuguang Wang,
and Fengtian He
|
34606-34616 |
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery |
https://doi.org/10.18632/oncotarget.5315
Chiara Romani,
Emiliano Cocco,
Eliana Bignotti,
Daniele Moratto,
Antonella Bugatti,
Paola Todeschini,
Elisabetta Bandiera,
Renata Tassi,
Laura Zanotti,
Sergio Pecorelli,
Enrico Sartori,
Franco E. Odicino,
Ario de Marco,
Alessandro Davide Santin,
Antonella Ravaggi,
and Stefania Mitola
|
34617-34628 |
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening |
https://doi.org/10.18632/oncotarget.5282
Maria Chiara Anania,
Fabio Gasparri,
Elena Cetti,
Ivan Fraietta,
Katia Todoerti,
Claudia Miranda,
Mara Mazzoni,
Claudia Re,
Riccardo Colombo,
Giorgio Ukmar,
Stefano Camisasca,
Sonia Pagliardini,
Marco A. Pierotti,
Antonino Neri,
Arturo Galvani,
and Angela Greco
|
34629-34648 |
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas |
https://doi.org/10.18632/oncotarget.5299
Ning Liu,
Rebecca J. Boohaker,
Chunling Jiang,
James R. Boohaker,
and Bo Xu
|
34649-34657 |
Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells
Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells |
https://doi.org/10.18632/oncotarget.5778
Jinjoo Park,
and Sunjoo Jeong
|
34658-34668 |
The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition
The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition |
https://doi.org/10.18632/oncotarget.5785
Weilong Yao,
Ping Yue,
Fadlo R. Khuri,
and Shi-Yong Sun
|
34669-34679 |
Next generation sequencing in synovial sarcoma reveals novel gene mutations
Next generation sequencing in synovial sarcoma reveals novel gene mutations |
https://doi.org/10.18632/oncotarget.5786
Myrella Vlenterie,
Melissa H.S. Hillebrandt-Roeffen,
Uta E. Flucke,
Patricia J.T.A. Groenen,
Bastiaan B.J. Tops,
Eveline J. Kamping,
Rolph Pfundt,
Diederik R.H. de Bruijn,
Ad H.M. Geurts van Kessel,
Han J.H.J.M. van Krieken,
Winette T.A. van der Graaf,
and Yvonne M.H. Versleijen-Jonkers
|
34680-34690 |
The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells
The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells |
https://doi.org/10.18632/oncotarget.5787
Evelyne Zeira,
Rinat Abramovitch,
Karen Meir,
Sharona Even Ram,
Yaniv Gil,
Baruch Bulvik,
Zohar Bromberg,
Or Levkovitch,
Nathalie Nahmansson,
Revital Adar,
Benjamin Reubinoff,
Eithan Galun,
and Michal Gropp
|
34691-34703 |
The transcription factor c-Fos coordinates with histone lysine-specific demethylase 2A to activate the expression of cyclooxygenase-2
The transcription factor c-Fos coordinates with histone lysine-specific demethylase 2A to activate the expression of cyclooxygenase-2 |
https://doi.org/10.18632/oncotarget.5474
Shaoli Lu,
Yang Yang,
Yipeng Du,
Lin-lin Cao,
Meiting Li,
Changchun Shen,
Tianyun Hou,
Ying Zhao,
Haiying Wang,
Dajun Deng,
Lina Wang,
Qihua He,
and Wei-Guo Zhu
|
34704-34717 |
STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation
STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation |
https://doi.org/10.18632/oncotarget.5303
Mao Ye,
Yani Tang,
Shijun Tang,
Jing Liu,
Kuangpei Wu,
Shan Yao,
Yang Sun,
Lei Zhou,
Tanggang Deng,
Ying Chen,
Chenghan Huang,
and Weihong Tan
|
34718-34731 |
Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment
Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment |
https://doi.org/10.18632/oncotarget.5300
Xiaorong Sun,
Ellen Ackerstaff,
Fuqiu He,
Ligang Xing,
Hung Tsung Hsiao,
Jason A. Koutcher,
C. Clifton Ling,
and Gloria C. Li
|
34732-34744 |
A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer
A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer |
https://doi.org/10.18632/oncotarget.5784
Edward J. Richards,
Jennifer Permuth-Wey,
Yajuan Li,
Y. Ann Chen,
Domenico Coppola,
Brett M. Reid,
Hui-Yi Lin,
Jamie K. Teer,
Andrew Berchuck,
Michael J. Birrer,
Kate Lawrenson,
Alvaro N.A. Monteiro,
Joellen M. Schildkraut,
Ellen L. Goode,
Simon A. Gayther,
Thomas A. Sellers,
and Jin Q. Cheng
|
34745-34757 |
CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer
CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer |
https://doi.org/10.18632/oncotarget.5325
Ling Lin,
Yong-Song Chen,
Yan-Dan Yao,
Jing-Qi Chen,
Jia-Ning Chen,
Song-Yin Huang,
Yun-Jie Zeng,
He-Rui Yao,
Si-Hai Zeng,
Yong-Shui Fu,
and Er-Wei Song
|
34758-34773 |
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases |
https://doi.org/10.18632/oncotarget.5793
Valerio Leoni,
Valentina Gatta,
Arianna Palladini,
Giordano Nicoletti,
Dario Ranieri,
Massimiliano Dall’Ora,
Valentina Grosso,
Martina Rossi,
Francesco Alviano,
Laura Bonsi,
Patrizia Nanni,
Pier-Luigi Lollini,
and Gabriella Campadelli-Fiume
|
34774-34787 |
PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway
PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway |
https://doi.org/10.18632/oncotarget.5858
Daisuke Fujimoto,
Yuki Ueda,
Yasuo Hirono,
Takanori Goi,
and Akio Yamaguchi
|
34788-34799 |
Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma
Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.5470
Hong-Xia Zhang,
Shan-Shan Jiang,
Xiao-Fei Zhang,
Zi-Qi Zhou,
Qiu-Zhong Pan,
Chang-Long Chen,
Jing-Jing Zhao,
Yan Tang,
Jian-Chuan Xia,
and De-Sheng Weng
|
34800-34817 |
Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway
Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway |
https://doi.org/10.18632/oncotarget.5397
Kyung Seok Han,
Na Li,
Pater A. Raven,
Ladan Fazli,
Sebastian Frees,
Susan Ettinger,
Ki Chung Park,
Sung Joon Hong,
Martin E. Gleave,
and Alan I. So
|
34818-34830 |
CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinoma
CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.5225
Juan Tang,
Yun-Shan Guo,
Xiao-Ling Yu,
Wan Huang,
Ming Zheng,
Ying-Hui Zhou,
Gang Nan,
Jian-Chao Wang,
Hai-Jiao Yang,
Jing-Min Yu,
Jian-Li Jiang,
and Zhi-Nan Chen
|
34831-34845 |
Transient rRNA synthesis inhibition with CX-5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells
Transient rRNA synthesis inhibition with CX-5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells |
https://doi.org/10.18632/oncotarget.5413
Sandeep S. Negi,
and Patrick Brown
|
34846-34858 |
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway |
https://doi.org/10.18632/oncotarget.5414
Yi-Hsien Hsieh,
Shu-Ching Hsieh,
Chien-Hsing Lee,
Shun-Fa Yang,
Chun-Wen Cheng,
Meng-Ju Tang,
Chia-Liang Lin,
Chu-Liang Lin,
and Ruey-Hwang Chou
|
34859-34874 |
A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth
A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth |
https://doi.org/10.18632/oncotarget.5332
A-Rum Yoon,
Jinwoo Hong,
and Chae-Ok Yun
|
34875-34891 |
Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors
Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors |
https://doi.org/10.18632/oncotarget.5408
Shinya Abe,
Kouhei Yamamoto,
Morito Kurata,
Shiho Abe-Suzuki,
Rie Horii,
Futoshi Akiyama,
and Masanobu Kitagawa
|
34892-34909 |
The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells
The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells |
https://doi.org/10.18632/oncotarget.5308
Liv-Marie Eike,
Nannan Yang,
Øystein Rekdal,
and Baldur Sveinbjørnsson
|
34910-34923 |
CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells
CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells |
https://doi.org/10.18632/oncotarget.5318
Qin-qin Li,
Le Zhang,
Hai-ying Wan,
Min Liu,
Xin Li,
and Hua Tang
|
34924-34940 |
Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development
Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development |
https://doi.org/10.18632/oncotarget.5472
Fung-Yu Huang,
Danny Ka-Ho Wong,
Wai-Kay Seto,
Ching-Lung Lai,
and Man-Fung Yuen
|
34941-34952 |
Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors
Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors |
https://doi.org/10.18632/oncotarget.5547
Yong-Qiang Liu,
Xiao-Lu Wang,
Xin Cheng,
Yong-Zhi Lu,
Gui-Zhen Wang,
Xin-Chun Li,
Jian Zhang,
Zhe-Sheng Wen,
Zhi-Liang Huang,
Qin-Lei Gao,
Li-Na Yang,
Yong-Xian Cheng,
Sheng-Ce Tao,
Jinsong Liu,
and Guang-Biao Zhou
|
34953-34967 |
miR-200c inhibits breast cancer proliferation by targeting KRAS
miR-200c inhibits breast cancer proliferation by targeting KRAS |
https://doi.org/10.18632/oncotarget.5198
Cailu Song,
Longzhong Liu,
Xiaoqing Pei,
Xiaoping Liu,
Lu Yang,
Feng Ye,
Xinhua Xie,
Jianping Chen,
Hailin Tang,
and Xiaoming Xie
|
34968-34978 |
HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma
HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma |
https://doi.org/10.18632/oncotarget.5512
Yuezhen Xue,
Shen Yon Toh,
Pingping He,
Thimothy Lim,
Diana Lim,
Chai Ling Pang,
Jean-Pierre Abastado,
and Françoise Thierry
|
34979-34991 |
Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation
Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation |
https://doi.org/10.18632/oncotarget.5252
Lakshmi Reddy Bollu,
Rajashekhara Reddy Katreddy,
Alicia Marie Blessing,
Nguyen Pham,
Baohui Zheng,
Xu Wu,
and Zhang Weihua
|
34992-35003 |
Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells
Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells |
https://doi.org/10.18632/oncotarget.5253
Dinesh Thotala,
Rowan M. Karvas,
John A. Engelbach,
Joel R. Garbow,
Andrew N. Hallahan,
Todd A. DeWees,
Andrei Laszlo,
and Dennis E. Hallahan
|
35004-35022 |
Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition
Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition |
https://doi.org/10.18632/oncotarget.5280
Fang Wei,
Xiao-Xiang Rong,
Rao-Ying Xie,
Li-Ting Jia,
Hui-Yan Wang,
Yu-Juan Qin,
Lin Chen,
Hong-Fen Shen,
Xiao-Lin Lin,
Jie Yang,
Sheng Yang,
Wei-Chao Hao,
Yan Chen,
Sheng-Jun Xiao,
Hui-Rong Zhou,
Tao-Yan Lin,
Yu-Shuang Chen,
Yan Sun,
Kai-Tai Yao,
and Dong Xiao
|
35023-35039 |
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma |
https://doi.org/10.18632/oncotarget.5319
Yoo-Young Lee,
Hye-Kyung Jeon,
Ji Eun Hong,
Young Jae Cho,
Ji Yoon Ryu,
Jung-Joo Choi,
Sang Hoon Lee,
Gun Yoon,
Woo Young Kim,
In-Gu Do,
Min Kyu Kim,
Tae-Joong Kim,
Chel Hun Choi,
Jeong-Won Lee,
Duk-Soo Bae,
and Byoung-Gie Kim
|
35040-35050 |
Re-irradiation for locally recurrent refractory breast cancer
Re-irradiation for locally recurrent refractory breast cancer |
https://doi.org/10.18632/oncotarget.6036
Tomas Merino,
William T. Tran,
and Gregory J. Czarnota
|
35051-35062 |
Multibeam inverse intensity-modulated radiotherapy (IMRT) for whole breast irradiation: a single center experience in China
Multibeam inverse intensity-modulated radiotherapy (IMRT) for whole breast irradiation: a single center experience in China |
https://doi.org/10.18632/oncotarget.5278
Zhaozhi Yang,
Li Zhang,
Xingxing Chen,
Jinli Ma,
Xin Mei,
Jiayi Chen,
Xiaoli Yu,
and Xiaomao Guo
|
35063-35072 |
Anti-α-enolase is a prognostic marker in postoperative lung cancer patients
Anti-α-enolase is a prognostic marker in postoperative lung cancer patients |
https://doi.org/10.18632/oncotarget.5316
Kuan-Chung Hsiao,
Neng-Yao Shih,
Pei-Yi Chu,
Yi-Mei Hung,
Jia-Yi Liao,
Shao-Wen Chou,
Yi-Yuan Yang,
Gee-Chen Chang,
and Ko-Jiunn Liu
|
35073-35086 |
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib |
https://doi.org/10.18632/oncotarget.5197
Luca Faloppi,
Maristella Bianconi,
Riccardo Giampieri,
Alberto Sobrero,
Roberto Labianca,
Daris Ferrari,
Sandro Barni,
Enrico Aitini,
Alberto Zaniboni,
Corrado Boni,
Francesco Caprioni,
Stefania Mosconi,
Silvia Fanello,
Rossana Berardi,
Alessandro Bittoni,
Kalliopi Andrikou,
Michela Cinquini,
Valter Torri,
Mario Scartozzi,
Stefano Cascinu,
and on behalf of the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
|
35087-35094 |
Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome
Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome |
https://doi.org/10.18632/oncotarget.4805
Aleksandar Radujkovic,
Natalia Becker,
Axel Benner,
Olaf Penack,
Uwe Platzbecker,
Friedrich Stölzel,
Martin Bornhäuser,
Ute Hegenbart,
Anthony D. Ho,
Peter Dreger,
and Thomas Luft
|
35095-35106 |
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study |
https://doi.org/10.18632/oncotarget.5959
Yuhong Li,
Miaozhen Qiu,
Jianming Xu,
Guoping Sun,
Huishan Lu,
Yunpeng Liu,
Meizuo Zhong,
Helong Zhang,
Shiying Yu,
Wei Li,
Xiaohua Hu,
Jiejun Wang,
Ying Cheng,
Juntian Zhou,
Zengqing Guo,
Zhongzhen Guan,
and Ruihua Xu
|
35107-35115 |
Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.5057
Jia-hong Wang,
Wei Wei,
Jing Xu,
Zhi-xing Guo,
Cheng-zuo Xiao,
Yong-fa Zhang,
Pei-en Jian,
Xiao-liang Wu,
Ming Shi,
and Rong-ping Guo
|
35116-35128 |